US FDA approves Amgen's Uplizna as first treatment for rare immune disorderU
Continue reading...
US FDA approves Amgen’s Uplizna as first treatment for rare immune...
US FDA approves Amgen's Uplizna as first treatment for rare immune disorder
The U.S. Food and Drug Administration has approved expanded use of Amgen's (AMGN.O),...
